An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
A new thesis from Karolinska Institutet aims to advance our understanding of the bidirectional relationship between ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...
Having itchy skin is usually nothing to worry about, but if it persists it could indicate something more serious.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...
Organ donation registration can be completed through the Ohio Bureau of Motor Vehicles. Living donors can contact one of two ...
1d
News Medical on MSNInnovative method improves understanding of cellular and molecular mechanisms in kidney diseasesResearchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...
AstraZeneca will gain full rights for roxadustat in China where it is approved to treat anaemia seen with chronic kidney ...
A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results